SECURITIES AND EXCHANGE COMMISSION
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Nevada | 333-57514 | 95-4834274 | ||
(State or other jurisdiction | (Commission | (IRS Employer | ||
of incorporation) | File Number) | Identification Number) |
120 W. Pomona Ave. Monrovia, California | 91016 | |
(Address of principal executive offices) | (Zip Code) |
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.06 Shell Company Status
The Company is NOT a a reporting “shell company, as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended. It is the determination of management and counsel Immunotech Laboratories Inc. F/K/A International Technology Systems Inc. F/K/A International Telecommuication, Inc. F/K/A EarthNetMedia Inc. has not nor has ever been a “shell” company.
Item 9.01 Financial Statements and Exhibits
d) Exhibit. See Attached
Exhibit
Number Description
99.1 Press Release
IMMUNOTECH LABORATORIES, INC. | ||||
Date: November 15, 2013 | By: | /s/ Harry Zhabilov | ||
Harry Zhabilov | ||||
President | ||||